skip to main content

H.R. 2484: Lowest Price for Patients Act


The text of the bill below is as of Apr 13, 2021 (Introduced).


I

117th CONGRESS

1st Session

H. R. 2484

IN THE HOUSE OF REPRESENTATIVES

April 13, 2021

(for herself, Ms. DeLauro, Mr. Grijalva, Mrs. Hayes, Mr. Khanna, Mr. Neguse, Mr. Larson of Connecticut, and Mr. Cohen) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to require pharmacies to disclose any differential between the cost of a prescription drug based on whether certain individuals use prescription drug coverage to acquire such drug, and for other purposes.

1.

Short title

This Act may be cited as the Lowest Price for Patients Act.

2.

Requirement for pharmacies to disclose any differential between the cost of a prescription drug based on whether certain individuals use prescription drug coverage to acquire such drug

(a)

Enrollees of prescription drug coverage under a group health plan or a health insurance issuer offering group or individual health insurance coverage

Section 2729(a) of the Public Health Service Act (42 U.S.C. 300gg–29(a)) is amended—

(1)

in paragraph (1)—

(A)

by striking not restrict, directly or indirectly, and inserting provide that; and

(B)

by striking from informing (or penalize such pharmacy for informing) and inserting inform; and

(2)

in paragraph (2)—

(A)

by striking ensure and inserting provide;

(B)

by striking does not, with respect to such plan or coverage, restrict, directly or indirectly, and inserting requires under such contract that; and

(C)

by striking from informing (or penalize such pharmacy for informing) and inserting inform.

(b)

Enrollees of prescription drug coverage under a prescription drug plan or MA–PD plan

Section 1860D–4 of the Social Security Act (42 U.S.C. 1395w–104) is amended—

(1)

by redesignating the subsection (m) as inserted by section 6063(c) of the SUPPORT for Patients and Communities Act as subsection (n); and

(2)

by adding at the end the following new subsection:

(o)

Pharmacy disclosure of the price of a drug for an enrollee using and not using prescription drug coverage

For plan year 2022 and each subsequent plan year, a PDP sponsor and a Medicare Advantage organization offering a prescription drug plan or MA–PD plan under a contract with an entity that provides pharmacy benefits management services on behalf of such MA–PD plan shall provide that each pharmacy that dispenses a coverage part D drug shall inform an enrollee of any differential between—

(1)

the price of the drug for an individual that is an enrollee under such prescription drug plan or MA–PD plan (as the case may be) using such plan; and

(2)

the price of the drug for such individual described in paragraph (1) without using such plan.

.